FFCP PHASE2:Hg19::chrX:68796176..68796181,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chrX:68796176..68796181, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chrX:68796176..68796181, - |
| Coexpression cluster: | C116_myeloma_xeroderma_tonsil_CD19_spleen_lymph_trachea |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chrX:68796176..68796181- |
|---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| chronic leukemia | 1.72e-37 | 8 |
| bone marrow cancer | 1.84e-34 | 1 |
| myeloma | 1.84e-34 | 1 |
| hematologic cancer | 6.21e-11 | 51 |
| immune system cancer | 6.21e-11 | 51 |
| myeloid leukemia | 2.60e-10 | 31 |
| leukemia | 2.42e-08 | 39 |
| sarcoma | 1.33e-07 | 20 |
Showing 1 to 8 of 8 entries
